View in EDS

Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies.

Saved in:
Bibliographic Details
Title: Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies.
Authors: Marques BS; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.; Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal., Mendes M; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. mmendes@ff.uc.pt.; Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal. mmendes@ff.uc.pt., Alves JL; Department of Neurosurgery, ULS Coimbra, Coimbra, Portugal.; Instituto Português de Oncologia, Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research, iCBR, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Pais A; Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal., Vitorino C; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. csvitorino@ff.uc.pt.; Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal. csvitorino@ff.uc.pt.
Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 Jul 15. Date of Electronic Publication: 2026 Jul 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2000
DOI:10.1007/s40291-026-00864-3